The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I study of BI 853520, an inhibitor of focal adhesion kinase (FAK), in patients with advanced or metastatic solid tumors.
 
Alona Zer
No Relationships to Disclose
 
Remy Verheijen
No Relationships to Disclose
 
Filip Yves Francine Leon De Vos
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Sebastien Hotte
Research Funding - Boehringer Ingelheim
 
Ferry Eskens
No Relationships to Disclose
 
Linda Pronk
Employment - Boehringer Ingelheim
 
Lillian L. Siu
Research Funding - Boehringer Ingelheim (Inst)
 
David Schnell
Employment - Boehringer Ingelheim
 
Neeltje Steeghs
No Relationships to Disclose
 
Marlies HG Langenberg
No Relationships to Disclose
 
Hal Hirte
Consulting or Advisory Role - AstraZeneca; Roche Pharma AG
 
Maja J. De Jonge
No Relationships to Disclose